These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38454627)

  • 1. Cannabis research in context: The case for measuring and embracing regional similarities and differences.
    Cousijn J; Kuhns L; Filbey F; Freeman TP; Kroon E
    Addiction; 2024 Sep; 119(9):1502-1504. PubMed ID: 38454627
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabis Use and Perinatal Health Research.
    Lo JO; Hedges JC; Metz TD
    JAMA; 2023 Sep; 330(10):913-914. PubMed ID: 37589991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What We Do (and Don't) Know About the Health Effects of Cannabis and Whether Marijuana Is Medicine.
    Patel S; Williams JW; Wallace RB
    Ann Intern Med; 2017 May; 166(10):747-748. PubMed ID: 28384665
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabis research: Risks of recreational use and potential medical applications.
    Maldonado R; Torrens M
    Eur Neuropsychopharmacol; 2020 Jul; 36():167-168. PubMed ID: 32620256
    [No Abstract]   [Full Text] [Related]  

  • 5. Recreational cannabis legalisation in the USA outpaces research into health effects.
    Furlow B
    Lancet Respir Med; 2017 May; 5(5):385-386. PubMed ID: 28320602
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabis research data reveals a focus on harms of the drug.
    O'Grady C
    Science; 2020 Sep; 369(6508):1155. PubMed ID: 32883844
    [No Abstract]   [Full Text] [Related]  

  • 7. A Decision 85 Years in the Making.
    Balla A; Solomon R; Piomelli D
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):723-724. PubMed ID: 36350696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marijuana Use for Women: To Prescribe or Not to Prescribe.
    Huang L; Zhang X; Xu A
    Subst Use Misuse; 2020; 55(12):2076-2077. PubMed ID: 32627638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students.
    Piercey CJ; Mataczynski M; Stallsmith VT; Emery NN; Karoly HC
    Cannabis Cannabinoid Res; 2024 Jun; 9(3):e917-e923. PubMed ID: 37699241
    [No Abstract]   [Full Text] [Related]  

  • 10. Hours high as a proxy for marijuana use quantity in intensive longitudinal designs.
    Calhoun BH; Patrick ME; Fairlie AM; Graupensperger S; Walukevich-Dienst K; Lee CM
    Drug Alcohol Depend; 2022 Nov; 240():109628. PubMed ID: 36126610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cannabis potency and mental health in adolescence.
    Hines LA; Cannings-John R; Hawkins J; Bonell C; Hickman M; Zammit S; Adara L; Townson J; White J
    Drug Alcohol Depend; 2024 Aug; 261():111359. PubMed ID: 38896946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affect and cannabis use in daily life: a review and recommendations for future research.
    Wycoff AM; Metrik J; Trull TJ
    Drug Alcohol Depend; 2018 Oct; 191():223-233. PubMed ID: 30149283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Protective Behavioral Strategies for Marijuana Scale (PBSM) short-form: Support for a two-factor structure and measurement invariance.
    Jordan HR; Hoover SM; Prince MA; Madson MB;
    Drug Alcohol Depend; 2022 Jul; 236():109489. PubMed ID: 35537318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Cannabis Demand: A Comprehensive Review of the Marijuana Purchase Task.
    Aston ER; Meshesha LZ
    Neurotherapeutics; 2020 Jan; 17(1):87-99. PubMed ID: 31916237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The virtues of bans on high-THC content cannabis products?
    Caulkins JP
    Addiction; 2023 Jun; 118(6):1004-1005. PubMed ID: 36709770
    [No Abstract]   [Full Text] [Related]  

  • 17. Examining links between cannabis potency and mental and physical health outcomes.
    Prince MA; Conner BT
    Behav Res Ther; 2019 Apr; 115():111-120. PubMed ID: 30497655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US Epidemiology of Cannabis Use and Associated Problems.
    Hasin DS
    Neuropsychopharmacology; 2018 Jan; 43(1):195-212. PubMed ID: 28853439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder.
    Sahlem GL; Tomko RL; Sherman BJ; Gray KM; McRae-Clark AL
    Int Rev Psychiatry; 2018 Jun; 30(3):216-225. PubMed ID: 29956576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates.
    Hammond CJ; Chaney A; Hendrickson B; Sharma P
    Int Rev Psychiatry; 2020 May; 32(3):221-234. PubMed ID: 32026735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.